Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-60
Closed -$938 728
2024
Q2
$938 Hold
60
﹤0.01% 894
2024
Q1
$947 Buy
+60
New +$1K ﹤0.01% 882
2023
Q4
Sell
-60
Closed -$1.11K 695
2023
Q3
$1.11K Hold
60
﹤0.01% 863
2023
Q2
$1K Hold
60
﹤0.01% 860
2023
Q1
$1K Hold
60
﹤0.01% 878
2022
Q4
$1K Hold
60
﹤0.01% 850
2022
Q3
$1K Hold
60
﹤0.01% 893
2022
Q2
$1K Hold
60
﹤0.01% 897
2022
Q1
$2K Hold
60
﹤0.01% 863
2021
Q4
$3K Hold
60
﹤0.01% 834
2021
Q3
$3K Hold
60
﹤0.01% 823
2021
Q2
$3K Hold
60
﹤0.01% 827
2021
Q1
$3K Hold
60
﹤0.01% 824
2020
Q4
$2K Hold
60
﹤0.01% 831
2020
Q3
$2K Hold
60
﹤0.01% 830
2020
Q2
$2K Hold
60
﹤0.01% 856
2020
Q1
$2K Hold
60
﹤0.01% 829
2019
Q4
$2K Hold
60
﹤0.01% 792
2019
Q3
$2K Hold
60
﹤0.01% 792
2019
Q2
$2K Hold
60
﹤0.01% 846
2019
Q1
$2K Hold
60
﹤0.01% 845
2018
Q4
$2K Hold
60
﹤0.01% 810
2018
Q3
$2K Hold
60
﹤0.01% 812
2018
Q2
$2K Hold
60
﹤0.01% 860
2018
Q1
$2K Sell
60
-1
-2% -$30 ﹤0.01% 797
2017
Q4
$2K Buy
+61
New +$1.85K ﹤0.01% 686

Other funds holding NEOG

Front Row Advisors's NEOG Position: Q3 2024 in Review

Front Row Advisors sold out of Neogen (NEOG) in Q3 2024, closing a stake of 60 shares — an estimated $938 sold.

Front Row Advisors first reported a position in NEOG in Q4 2017 and held it in 26 quarters. The position peaked at $3K in Q4 2021. 338 funds tracked by Wall St. Rank hold NEOG as of Q3 2024.

  • Front Row Advisors reported no remaining Neogen position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 60 Neogen shares in Q3 2024, an estimated $938.
  • Front Row Advisors first reported a position in Neogen in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Neogen position peaked at $3K in Q4 2021.
  • 338 funds tracked by Wall St. Rank held Neogen as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.